Pages that link to "Q30355260"

The following pages link to HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development (Q30355260):

Displaying 13 items.

• HIV-1 vaccines: challenges and new perspectives (Q33577972) (← links)
• Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines (Q34057711) (← links)
• Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation (Q34309493) (← links)
• Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry (Q34875765) (← links)
• Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor (Q35857404) (← links)
• The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development (Q38243948) (← links)
• Structural Elements Recognized by Abacavir-Induced T Cells (Q38689568) (← links)
• A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice (Q41424896) (← links)
• Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes. (Q42204816) (← links)
• Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant (Q47105347) (← links)
• The Role of Integrin α4β7 in HIV Pathogenesis and Treatment. (Q52686548) (← links)
• Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India (Q57167018) (← links)
• Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates (Q92255379) (← links)